Early Infectious Disease Outpatient Follow-up of Outpatient Parenteral Antimicrobial Therapy Patients Reduces 30-Day Readmission

Ena Saini; Mohammad Ali; Ping Du; Tonya Crook; John Zurlo

doi:10.1093/cid/ciz073

Early Infectious Disease Outpatient Follow-up of Outpatient Parenteral Antimicrobial Therapy Patients Reduces 30-Day Readmission

Clin Infect Dis. 2019 Aug 16;69(5):865-868. doi: 10.1093/cid/ciz073.

Authors

Ena Saini¹, Mohammad Ali¹, Ping Du^{1

2}, Tonya Crook¹, John Zurlo¹

Affiliations

¹ Department of Medicine, Penn State Hershey College of Medicine, Hershey, Pennsylvania.
² Department of Public Health Sciences, Penn State Hershey College of Medicine, Hershey, Pennsylvania.

PMID: 30721936
DOI: 10.1093/cid/ciz073

Abstract

We conducted a case-control study to examine the association between outpatient infectious disease (ID) follow-up and risk of 30-day readmission in 384 patients receiving outpatient parenteral antimicrobial therapy. ID outpatient follow-up within 2 weeks was associated with lower risk of all-cause 30-day readmission (adjusted odds ratio, 0.33; P = .0001).

Keywords: 30-day readmission; infectious disease follow-up; outpatient parenteral antimicrobial therapy; OPAT.

MeSH terms

Aftercare*
Anti-Bacterial Agents / therapeutic use*
Case-Control Studies
Communicable Diseases / drug therapy*
Communicable Diseases / microbiology
Female
Humans
Infusions, Parenteral
Male
Middle Aged
Outpatients*
Patient Readmission / statistics & numerical data*
Retrospective Studies
Risk Factors

Substances

Anti-Bacterial Agents